Results 121 to 130 of about 556,889 (346)
Novel Approaches in Glycogen Storage Disease Type I Management: Harnessing the Potential of Micronutrients and Macro Molecules [PDF]
, 2023 Santosh B. Patil, Pramod C. Gadad
openalex +1 more source
Renal Disease in an Adult Patient with Type I Glycogen Storage Disease
Renal Failure, 1995 A 26-year-old Chinese male patient with type I glycogen storage disease presented with chronic renal disease, proteinuria, and urolithiasis. On renal biopsy, focal glomerular sclerosis, increased mesangial matrix and cellularity, interstitial fibrosis, tubular atrophy, and prominent arteriosclerosis were observed. Immunofluorescence microscopy revealed
Benny Kho, Paik-Seong Lim
openaire +3 more sources
Food Frontiers, EarlyView.ABSTRACT To improve the comprehensive utilization of Siraitia grosvenorii (Swingle) C. Jeffrey, a novel polysaccharide (SGP) was isolated from the mogroside waste liquid of S. grosvenorii. In addition, ferulic acid–SGP (FA‐SGP) and caffeic acid–SGP (CA‐SGP) were prepared by modifying SGP with phenolic acid.
Jiajing Duan +6 more
wiley +1 more source
Journal of Lipid Research, 1988 With the advent of nocturnal intragastric feeding which protects against acute metabolic complications and promotes growth, patients with glycogen storage disease type I are attracting less attention.
E Levy +5 more
doaj
Exploring the Molecular Pathways Underlying the Anti‐Diabetic Effects of Millets
Food Safety and Health, EarlyView.Millet consumption may modulate gluconeogenesis and glycolysis, enhance glucose transporter activity, increase leptin levels, inhibit the NF‐κB pathway, and mitigate oxidative and nitrosative stress. ABSTRACT Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemic conditions resulting from inadequate insulin production or ...
Akash Kumar +5 more
wiley +1 more source
European Journal of Neurology, Volume 30, Issue 2, Page 399-412, February 2023., 2023 Abstract Background and purpose Clinical outcome information on patients with neuromuscular diseases (NMDs) who have been infected with SARS‐CoV‐2 is limited. The aim of this study was to determine factors associated with the severity of COVID‐19 outcomes in people with NMDs.
Chiara Pizzamiglio +93 more
wiley +1 more source
Hepatic stress associated with pathologies characterized by disturbed glucose production
Cell Stress, 2019 The liver is an organ with many facets, including a role in energy production and metabolic balance, detoxification and extraordinary capacity of regeneration. Hepatic glucose production plays a crucial role in the maintenance of normal glucose levels in
Monika Gjorgjieva +2 more
doaj +1 more source
Energy Autonomous Wearable Sensors for Smart Healthcare: A Review [PDF]
Journal of The Electrochemical Society, Electrochemical Society,
2019, JES Focus Issue on Sensor Reviews, 167 (3), 2019 Energy Autonomous Wearable Sensors (EAWS) have attracted a large interest due to their potential to provide reliable measurements and continuous bioelectric signals, which help to reduce health risk factors early on, ongoing assessment for disease prevention, and maintaining optimum, lifelong health quality.
arxiv
Dynamics of epidemic diseases without guaranteed immunity [PDF]
arXiv, 2020 The global SARS-CoV-2 pandemic suggests a novel type of disease spread dynamics. WHO states that there is currently no evidence that people who have recovered from COVID-19 and have antibodies are immune from a second infection [WHO]. Conventional mathematical models consider cases for which a recovered individual either becomes susceptible again or ...
arxiv
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease. [PDF]
, 2017 BackgroundLate-onset Pompe disease is a rare genetic neuromuscular disorder caused by lysosomal acid alpha-glucosidase (GAA) deficiency that ultimately results in mobility loss and respiratory failure.
Barohn, Richard +15 more
core +2 more sources